NFKB1 and metabolic dysfunction-associated steatotic liver disease: From the aforementioned results, we found that GLC can attenuate the inflammatory process in the liver of HFHSD-fed NAFLD mice by LPS/TLR4/NF-κB inflammatory pathway activation and regulating the expression of related inflammatory factors in the pathway.